In the News
powered by Ovast-
Drug Maker Endo Gets Input In House Bill On Generics
nytimes.com 11 hours, 16 minutes agoA lobbying effort by Endo Pharmaceuticals led to language in a House measure requiring the F.D.A. to develop new ways of measuring the equivalence of “locally acting” generic and brand-name medicines.
-
Generics Drive Down Drug Prices In India, TPP Trying To Stop That
techdirt.com 6 days, 10 hours agoBack in March, we wrote about an important development in India, where a compulsory license for Bayer's Nexavar anti-cancer drug was granted. Bayer, of course, is fighting back : in its 37-page appeal to the Intellectual Property Appellate Board, Bayer has "demanded the withdrawal of the country’s first compulsory license given to Natco Pharma, arguing that a three-fourths reduction in the price of the anti-cancer drug by another Indian firm has made the permit redundant and its patent itself is vulnerable


Loading More Stories